Treatment of Cerebral Arteriovenous Malformations with a New Liquid Embolic Agent (Onyx18)

王雷,罗祺,曹镇洋,王雨琳
DOI: https://doi.org/10.3969/j.issn.1004-0412.2007.03.012
2007-01-01
Abstract:Objective To discuss the application value and technique characteristic of a new liquid embolic agent(Onyx18) in the treatment of cerebral arteriovenous malformations(cAVM).Method Onyx18 was used to treat 5 cases with cAVM.The diameter of cAVM was below 3cm in 1 case,3~6cm in 3 cases and over 6 cm in 1 case.According to Spetzler-Martin grade,there were 1 case of grade II,2 of grade Ⅲ and 2 of grade Ⅳ.Results Among the 5 patients,2 acquired 100% embolization,1 acquired 90% embolization and 2 acquired 75% embolization. Conclusion Compared with NBCA,Onyx18 is an optimal embolization material in the treatment of cAVM,but it's necessary to master the correct embolization technique to avoid complications.However,the long-term efficacy of Onyx18 embolization needs to be followed up.
What problem does this paper attempt to address?